Fennec Pharmaceuticals Inc.
FENCNasdaqCIK 1211583HealthcareFiscal year ends Dec 31
Reports and events: 242 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1720:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108565 |
| 2026-08-1320:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-095884 |
| 2026-06-1021:19 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-072425 |
| 2026-05-2220:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065696 |
| 2026-05-1821:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-063271 |
| 2026-05-1420:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-061213 |
| 2026-04-2820:46 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-050433 |
| 2026-04-2820:09 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001104659-26-050339 |
| 2026-04-2220:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-046804 |
| 2026-04-0720:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040414 |
| 2026-03-2720:44 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-036182 |
| 2026-03-2420:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-033885 |
| 2026-03-1621:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028595 |
| 2026-03-0421:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023484 |
| 2026-02-2021:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-018128 |
| 2025-12-0921:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-119654 |
| 2025-12-0221:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117697 |
| 2025-11-1912:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-113915 |
| 2025-11-1821:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-113646 |
| 2025-11-1711:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112912 |
| 2025-11-1321:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-111260 |
| 2025-08-1420:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011552 |
| 2025-06-0320:31 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-055992 |
| 2025-05-1420:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007748 |
| 2025-04-2520:25 ET | DEF 14A | Proxy statementPeriod 2025-06-03 | 0001558370-25-005563 |
| 2025-03-2620:34 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003710 |
| 2025-03-1020:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002599 |
| 2025-02-0721:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000715 |
| 2024-12-2021:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-130855 |
| 2024-12-2021:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-130854 |
| 2024-11-0821:46 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015068 |
| 2024-10-3011:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-112405 |
| 2024-08-1321:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012074 |
| 2024-08-0722:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-086369 |
| 2024-07-0221:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-076936 |
| 2024-06-2520:11 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-074748 |
| 2024-05-1421:24 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008162 |
| 2024-05-1320:42 ET | DEF 14A | Proxy statementPeriod 2024-06-25 | 0001558370-24-007979 |
| 2024-05-0900:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-058960 |
| 2024-03-2920:14 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-004383 |
| 2024-03-2520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-038444 |
| 2024-03-2120:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-037255 |
| 2024-03-0621:07 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-031470 |
| 2024-02-2921:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-029355 |
| 2024-02-0223:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-009551 |
| 2023-12-0601:51 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-123728 |
| 2023-11-0921:52 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018614 |
| 2023-11-0700:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-114905 |
| 2023-08-0721:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-013638 |
| 2023-08-0714:51 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-088184 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.